- Prebiotics for Infant Formula, particularly those containing galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS), are gaining traction for promoting healthy gut microbiota, boosting immunity, and supporting overall infant health
- Market demand is largely driven by the shift toward functional and fortified baby food, increased penetration of international infant formula brands, and greater healthcare professional endorsements for prebiotic inclusion
- The growing preference for close-to-breastmilk substitutes and increasing focus on pediatric nutrition innovation are expected to further accelerate the adoption of prebiotic-enriched infant formulas in Asia-Pacific
- Japan dominated the Asia-Pacific prebiotics for infant formula market in 2024, accounting for the largest revenue share of 54.89%, driven by strong parental preference for high-quality, science-backed infant nutrition
- China is projected to be the fastest-growing market with the highest CAGR of 8.66% in Asia-Pacific from 2025 to 2032, propelled by a large infant population, rising disposable income, and a shift toward premium infant nutrition
- The Human Milk Oligosaccharides (HMOs) segment dominated the market with the largest revenue share of 36.4% in 2024, owing to their close resemblance to naturally occurring prebiotics found in breast milk
